Human Glycogen synthase 2 (GYS2) activation kit by CRISPRa

CAT#: GA102036

GYS2 CRISPRa kit - CRISPR gene activation of human glycogen synthase 2



Find the corresponding CRISPRi Inhibitor Kit

Product Images

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol GYS2
Locus ID 2998
Kit Components

GA102036G1, Glycogen synthase 2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA102036G2, Glycogen synthase 2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA102036G3, Glycogen synthase 2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_021957
UniProt ID P54840
Synonyms glycogen synthase 2 (liver)
Summary The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]

Documents

Other Versions